Cerenome is trading 5.77% up at $1.65 in pre-market on October 6, 2026, compared with the October 5 close of $1.56. No clear company-specific catalyst for the move was identified.
- The latest listed filing is an October 2 Form 8-K. Available filing information identifies an investor presentation, not a new material announcement explaining the gain.
- Major U.S. indexes are also higher pre-market, but there is not enough evidence to attribute Cerenome’s move to the broader market.